BioSpace News Archive

Verve Therapeutics to Present at the 39 th Annual J.P. Morgan Healthcare Conference

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services directly into Medicare focused clinics using its proprietary MedCenter solution, today announced that the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference. MedAvail’s management is sc

Company to Expand R&D Focus for Pipeline Growth to include Earlier Stage Programs and Validated Technology Platforms Firdapse® 2020 Net Revenues Estimate of approximately $118 Million; about 16% Increase From 2019 Ended 2020 with Estimated $140 Million in Cash and Investments Company Highlights Current Product Development Programs

UroGen Pharma to Present at the Virtual 39 th Annual J.P. Morgan Healthcare Conference